Carter King

Carter King serves as the Executive Vice President of Business Development at Protagonist Therapeutics, leading initiatives for a clinical stage biotechnology company specializing in novel peptide therapeutics for inflammatory diseases. Previous experience includes roles as Business Development Consultant at Achaogen, focusing on licensing strategies for novel antibacterials, and Vice President positions at Omniox, Inc., AcelRx Pharmaceuticals, and ALZA Corporation, where responsibilities spanned finance, corporate development, and market strategy. Educational qualifications include an M.B.A. in Finance from Columbia Business School and a BA in Business Economics from UC Santa Barbara.